Investors with a long-term perspective and a goal of building wealth have a completely different perspective on bear markets than traders. Read More
Analyst Articles
In the September issue of Roadrunner Stocks, two new BUY recommendations have been issued. 1. The Value Portfolio is adding real-estate finance company Stewart Information Services (STC).2. The Momentum Portfolio is adding industrial conglomerate Valmont Industries (VMI). Read More . . . Read More
With the global economy recovering, two economically-sensitive growth stocks with low valuations in the industrial and real-estate-finance sectors have bright futures and should outperform. Read More
A couple of Roadrunner companies were downgraded by Wall Street analysts, but after reading the reasons behind the downgrades, one must conclude that the downgrades simply rationalize the past rather than predict the future. Read More
Government shutdown threats, debt ceiling deadline, and uncertain Fed QE tapering are in the bullseye of investors. Read More
“If I had $10,000 to invest, I would focus on smaller companies, because there would be a greater chance that something was overlooked in that arena.” —Warren Buffett Here are just three reasons why you need to hold top-flight small-cap stocks right now: Higher returns: If you had invested in… Read More
In the August issue of Roadrunner Stocks, two new BUY recommendations have been issued. 1. The Value Portfolio is adding hazardous waste manager US Ecology (ECOL)2. The Momentum Portfolio is adding hospital bed manufacturer Hill-Rom Holdings (HRC). Read More . . . Read More
An industrial company with an impenetrable market position in an oligopoly business and a healthcare equipment supplier with a leading market share and an honest management team that returns cash to stockholders is a winning combination of investments. Read More
An autumn market correction followed by new all-time highs is a likely scenario. Read More
More Roadrunner companies report Q2 earnings, including a tech company ready to make a roaring comeback and a biotech company offering up an incredibly optimistic forecast. Read More